Skip to main content
. 2019 Mar 5;10(19):1850–1859. doi: 10.18632/oncotarget.26753

Figure 1.

Figure 1

Change from baseline in pERK and DUSP6 expression in patients with (A) BRAF or (B) NRAS mutation and correlation with best overall response. Single dots represent unpaired biopsies. BOR, best overall response; Cq, quantification cycle; PD, progressive disease; PR, partial response; SD, stable disease; UNK, unknown.